Amgen Inc (NASDAQ:AMGN)
| 222.96 Delayed Data As of Feb 19 |  +1.27 / +0.57%Today’s Change | 166.30 Today|||52-Week Range 244.99 | -7.51% Year-to-Date |
Latest AMGN News | Press Releases
| 3 Biotech Stocks That Made Early Shareholders Millionaires Feb 13 / MotleyFool.com - Paid Partner Content | Is Amgen a Stock to Buy? Feb 08 / MotleyFool.com - Paid Partner Content |
| Bristol-Myers Squibb Stock Is Too Cheap to Ignore Feb 10 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 221.69 |
| Today’s open | 222.94 |
| Day’s range | 222.05 - 224.05 |
| Volume | 1,322,884 |
| Average volume (3 months) | 2,241,702 |
| Market cap | $131.7B |
Data as of 4:00pm ET, 02/19/2020
Growth & Valuation
| Earnings growth (last year) | +2.07% |
| Earnings growth (this year) | +6.57% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | -2.13% |
| P/E ratio | 17.3 |
| Price/Sales | 6.31 |
| Price/Book | 13.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +0.34 | +0.51% |
| BIIBBiogen | +3.94 | +1.17% |
| ILMNIllumina Inc | +3.28 | +1.09% |
| BMRNBiomarin Pharmaceuti... | +0.93 | +1.05% |
Data as of 4:00pm ET, 02/19/2020
Financials
| Next reporting date | April 28, 2020 |
| EPS forecast (this quarter) | $3.78 |
| Annual revenue (last year) | $23.3B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 33.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
